方達控股(01521.HK)擬1321.5萬美元收購美國合同研究機構服務公司88.1%股權
格隆匯7月28日丨方達控股(01521.HK)發佈公吿,2022年7月27日(紐約時間),Frontage Labs作為買方(公司全資附屬公司)與賣方(即SunRex LLC與個別賣方)、代表及目標公司(公司的聯繫人)訂立購股協議,據此,買方同意購買目標公司的88.1%股權,現金代價約為1321.5萬美元(相當於約1.037億港元)。交割前,買方擁有目標公司的11.9%股權。緊隨交割後,買方將擁有目標公司的全部股權。
目標公司(即Frontage Clinical Services, Inc.)於美國德拉瓦州註冊成立,主要從事提供臨牀調查研究方面的合同研究機構服務。緊接交割前,目標公司直接由SunRex持有約67.9%,由8名個別賣方合共持有約20.2%(各自持有目標公司少於6%),以及由Frontage Labs持有11.9%。
公吿表示,通過內生增長及潛在收購為客户提供進一步綜合解決方案,從而擴展公司的服務範圍是公司的策略之一。收購事項將擴大集團在I期臨牀測試、煙草研究及人體吸收、代謝和排泄研究的臨牀研究服務的能力,並將增強集團通過其他科學家、人員、設備及設施提供該等服務的能力。因此,董事會認為收購事項可能擴大集團的收益基礎,並強化集團作為合同研究機構行業全球領導者的地位。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.